Abstract:Patent foramen ovale (PFO) represents the most common congenital heart disease (CHD) among subjects from general population having a prevalence ranging between 20 and 30% [ [1] Rigatelli G. Pedon L. Zecchel R. Dell’Avvocata F. Carrozza A. Zennaro M. Mazza A. Zuin M. Russo M. Zanchetta M. Long-term outcomes and complications of Intracardiac echocardiography-assisted patent foramen ovale closure in 1,000 consecutive patients. J. Interv. Cardiol. 2016; 29: 530-538https://doi.org/10.1111/joic.12325 Crossref PubMed Scopus (31) Google Scholar ]. Over the years, several investigations have demonstrated that PFO is implicated in the pathogenesis of different medical conditions [ 2 Rigatelli G. Dell’Avvocata F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Mandapaka S. Kuruvilla J. Chen J.P. Nanjundappa A. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J. Am. Coll. Cardiol. 2011; 58: 2257-2261https://doi.org/10.1016/j.jacc.2011.06.06422078434 Crossref PubMed Scopus (55) Google Scholar , 3 Zuin M. Rigatelli G. Rigatelli A. Ronco F. Conte L. Roncon L. Mazza A. Correlations between serum homocysteine levels and RoPE score in patients with patent foramen ovale. Heart Vessel. 2020; 35: 705-711https://doi.org/10.1007/s00380-019-01528-5 Crossref PubMed Scopus (3) Google Scholar , 4 Rigatelli G. Dell’Avvocata F. Ronco F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Rigatelli G. Chen J.P. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc. Interv. 2010; 3: 282-287https://doi.org/10.1016/j.jcin.2009.11.019 Crossref PubMed Scopus (36) Google Scholar ] though two main mechanisms: the former represented by the “traditional” paradoxical embolism and the latter due to the Right-to-Left shunt (RLS)-induced left atrial cardiomyopathy [ [5] Rigatelli G. Aggio S. Cardaioli P. Braggion G. Giordan M. Dell’avvocata F. Chinaglia M. Rigatelli G. Roncon L. Chen J.P. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?. JACC Cardiovasc. Interv. 2008; 2: 655-662https://doi.org/10.1016/j.jcin.2009.05.010 Crossref Scopus (89) Google Scholar , [6] Rigatelli G. Zuin M. Adami A. Aggio S. Lanza D. d’Elia K. Braggion G. Russo M. Mazza A. Roncon L. Left atrial enlargement as a maker of significant high-risk patent foramen ovale. Int. J. Card. Imaging. 2019; 35: 2049-2056https://doi.org/10.1007/s10554-019-01666-x Crossref Scopus (10) Google Scholar ]. Notably, during the latest two decades, due to the widespread diffusion of echocardiography, the identification of either asymptomatic or thrombus straddling a PFO (TSPFO) has drastically increased, especially in patients with some life-threatening disease such as acute pulmonary embolism (PE) or ischemic stroke (IS) [ 7 Zhang M. Tan S. Patel V. Zalta B.A. Shmukler A. Levsky J.M. Jain V.R. Shaban N.M. Haramati L.B. Patent foramen ovale in patients with pulmonary embolism: a prognostic factor on CT pulmonary angiography?. J. Cardiovasc. Comput.Tomogr. 2017; 12: 271-274https://doi.org/10.1016/j.jcct.2017.11.009 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar , 8 Rigatelli G. Zuin M. Not all patent foramen ovales are alike!. Thromb. Res. 2021; 203: 81https://doi.org/10.1016/j.thromres.2021.04.022 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar , 9 Consoli D. Paciaroni M. Aguggia M. Melis M. Malferrari G. Vidale S. Cerrato P. Sacco S. Gandolfo C. Bovi P. Serrati C. Del Sette M. Cavallini A. Diomedi M. Postorino P. Ricci S. Prevalence of patentforamen ovale in ischemic stroke in Italy: the SISIFO study. Neurol. Sci. 2014; 35: 867-873https://doi.org/10.1007/s10072-013-1615-2 Crossref PubMed Scopus (6) Google Scholar ]. As a matter of a fact, in current daily clinical practice, TSPFO is generally recognized as a source of acute IS. In this number of the journal, Shah and colleagues performed an interesting analysis based on patient-level data, investigating whether acute myocardial infarction (AMI) or IS in patients having TSPFO upon the admission, may be associated with a higher in-hospital mortality [ [10] Shah P. Jimenez-Ruiz A. Gibson A. Vargas-González J.C. Bres-Bullrich M. Bagur R. Sposato L.A. Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale. Int. J. Cardiol. 2021; S0167-5273 (Epub ahead of print): 01101-01103https://doi.org/10.1016/j.ijcard.2021.07.007 Abstract Full Text Full Text PDF Scopus (1) Google Scholar ]. For this purpose, the authors performed a systematic search, without language restrictions, describing case-reports or series of adult patients with TSPFO between 1950 to October 30, 2020.

Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses

Safety and Long-Term Results of Patent Foramen Ovale Transcatheter Closure in Patients with Thrombophilia.

Patent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trials.

Patent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trials [version 2; referees: 2 approved]

Patent Foramen Ovale Closure for Patients with Cryptogenic Stroke: A Systematic Review and Comprehensive Meta‐analysis of 5 Randomized Controlled Trials and 14 Observational Studies

Comparison of Stroke Recurrence Between Antiplatelet and Closure Therapy in Cryptogenic Stroke Patients with Patent Foramen Ovale and Its Influencing Factors

Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke

Percutaneous Closure Versus Medical Therapy for Stroke with Patent Foramen Ovale: a Systematic Review and Meta-Analysis

Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation in Patients with Patent Foramen Ovale and Cryptogenic Stroke: a Systematic Review and Network Meta-Analysis Incorporating Complementary External Evidence

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Recurrent Ischemic Stroke/Transient Ischemic Attack After Patent Foramen Ovale Closure: A cohort study

[Patent foramen ovale and stroke]

Patent Foramen Ovale: a Comprehensive Review for Pulmonologists

Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?

Patent foramen ovale and stroke in childhood: A systematic review of the literature

Thrombus Straddling a Patent Foramen Ovale: Also a Myocardial Infarction Matter?

A Detailed Systematic Review Comparing Patent Foramen Ovale Closure vs Medical Therapy for the Prevention of Recurrent Cryptogenic Stroke

Patent Foramen Ovale Closure or Medical Therapy for Secondary Prevention of Cryptogenic Stroke: an Update Meta-Analysis of Randomized Controlled Trials.

Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale

Patent Foramen Ovale with Paradoxical Embolism: Mid‐Term Results of Transcatheter Closure in 256 Patients

Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study.